Mode
Text Size
Log in / Sign up
N/A N=2 Other

3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair

Abdominal Aortic Aneurysm

Enrolled (actual)
2
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Number of Participants With Successful Implantation of Cook Zenith AAA Endovascular Graft Using the 3D-GN&C Device — 2 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
3D Holographic Guidance, Navigation, and Control (3D GN&C) (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
The Cleveland Clinic
Primary completion
Jun 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Successful Implantation of Cook Zenith AAA Endovascular Graft Using the 3D-GN&C Device
2
SECONDARY
Delivery System Placement in the Intended Location
2

Summary

This is an Early Feasibility Study to evaluate the usability, safety and functionality of 3D holographic guidance, navigation, and control (3D-GNC) as an adjunct to and confirmed by fluoroscopic imaging to be used with Cook Zenith Flex AAA Endovascular Graft®.

Eligibility Criteria

Inclusion Criteria

  • The patient meets the instructions for use (IFU) for the 24-28 mm body Cook Zenith Flex AAA bifurcated stent graft.
  • Adequate iliac/femoral access compatible with the required introduction system
  • Non aneurysmal infrarenal aortic segment (neck) proximal to the aneurysm:

i. With a length of at least 15mm ii. With a diameter measured outer wall to outer wall of no greater than 26mm and no less than 20mm iii. With an angle less than 60 degrees relative to the long access of the aneurysm and iv. With an angle less than 45 degrees relative to the axis of the suprarenal aorta c. Iliac artery distal fixation site greater than 10mm in length and 7.5-20mm in diameter (measured outerwall to outerwall).

  • Male/female, aged ≥ 18
  • Patient fulfilling criteria for needing endovascular repair of abdominal aortic aneurysm according to routine clinical practice criteria of the participating center
  • Women of childbearing potential must be non-pregnant, non-lactating, and not planning to become pregnant during the course of the trial; and have a negative urine or serum pregnancy test within 7 days prior to index procedure
  • Provide written informed consent as applicable and defined by site country regulation
  • Stated willingness to comply with all study procedures and availability for the duration of the study

Exclusion Criteria

An individual who meets any of the following criteria will be excluded from participation in this study:

  • Contraindications for Cook Zenith Flex Aortic endograft:
  • Patients with known sensitivities or allergies to stainless steel, polyester, solder (tin, silver), polypropylene, or gold
  • Patients with a systemic infection who may be at increased risk of endovascular graft infection
  • Presence of electronic implants, e.g., cardiac pacemaker, automatic implantable cardioverter/defibrillator (AICD) or nerve stimulator
  • Presence of metallic implants above the knee, e.g., artificial hip
  • Patients not willing or able to give informed consent
  • Pregnant women
  • Patients' inability to have a contrasted CT scan
  • Current or planned participation in any other investigational drug or medical device clinical study that has not completed primary endpoint(s) evaluation;
  • Other medical, social, or psychological issues that in the opinion of the investigator preclude the subjects from receiving this treatment, and the procedures and evaluations pre- and posttreatment
  • Anatomy outside of the IFU for a 24-28 mm Cook Zenith Flex AAA bifurcated stent graft
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06008613). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search